Oncolytics Biotech Inc (ONC) — Cash Flow-to-Debt Ratio
Oncolytics Biotech Inc (ONC) has a Cash Flow-to-Debt Ratio of -0.39x as of June 2025, meaning its operating cash flow of CA$-5.47 Million could theoretically repay 0% of its total liabilities (CA$13.88 Million) in one year. See Oncolytics Biotech Inc free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Oncolytics Biotech Inc Cash Flow-to-Debt Ratio (1999–2024)
Historical debt coverage capacity for Oncolytics Biotech Inc across 26 annual periods. Also explore Oncolytics Biotech Inc (ONC) equity growth momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Oncolytics Biotech Inc (1999–2024)
Year-by-year debt coverage analysis for Oncolytics Biotech Inc. For market capitalisation and broader financial context, see ONC company net worth.
| Year | CF-to-Debt Ratio | Operating CF (CAD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -1.90x | CA$-26.97 Million | CA$14.20 Million | ▲ +24.9% |
| 2023 | -2.53x | CA$-28.45 Million | CA$11.26 Million | ▼ -17.2% |
| 2022 | -2.16x | CA$-23.36 Million | CA$10.83 Million | ▲ +6.0% |
| 2021 | -2.29x | CA$-22.43 Million | CA$9.78 Million | ▲ +0.3% |
| 2020 | -2.30x | CA$-22.07 Million | CA$9.59 Million | ▼ -128.4% |
| 2019 | -1.01x | CA$-19.91 Million | CA$19.77 Million | ▲ +26.8% |
| 2018 | -1.37x | CA$-11.92 Million | CA$8.67 Million | ▲ +8.9% |
| 2017 | -1.51x | CA$-14.89 Million | CA$9.87 Million | ▲ +50.8% |
| 2016 | -3.07x | CA$-12.48 Million | CA$4.07 Million | ▲ +44.7% |
| 2015 | -5.55x | CA$-15.03 Million | CA$2.71 Million | ▲ +4.9% |
| 2014 | -5.83x | CA$-19.68 Million | CA$3.37 Million | ▼ -43.4% |
| 2013 | -4.07x | CA$-24.44 Million | CA$6.01 Million | ▲ +13.4% |
| 2012 | -4.70x | CA$-34.26 Million | CA$7.29 Million | ▼ -35.6% |
| 2011 | -3.47x | CA$-22.54 Million | CA$6.50 Million | ▲ +51.9% |
| 2010 | -7.21x | CA$-18.03 Million | CA$2.50 Million | ▼ -89.8% |
| 2009 | -3.80x | CA$-16.82 Million | CA$4.43 Million | ▼ -12.7% |
| 2008 | -3.37x | CA$-15.29 Million | CA$4.53 Million | ▲ +29.9% |
| 2007 | -4.81x | CA$-13.57 Million | CA$2.82 Million | ▼ -9.5% |
| 2006 | -4.39x | CA$-12.16 Million | CA$2.77 Million | ▲ +26.8% |
| 2005 | -6.00x | CA$-11.05 Million | CA$1.84 Million | ▲ +28.5% |
| 2004 | -8.39x | CA$-9.22 Million | CA$1.10 Million | ▼ -58.6% |
| 2003 | -5.29x | CA$-5.48 Million | CA$1.03 Million | ▼ -2.9% |
| 2002 | -5.15x | CA$-7.26 Million | CA$1.41 Million | ▼ -275.5% |
| 2001 | -1.37x | CA$-4.27 Million | CA$3.12 Million | ▲ +24.4% |
| 2000 | -1.81x | CA$-3.16 Million | CA$1.74 Million | ▲ +19.9% |
| 1999 | -2.26x | CA$-534.35K | CA$236.10K | — |